Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (81-90 of 208) with videos related to

Pageof 21
Sort By:
Journal of Clinical Medicine|August 7, 2021
Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life SettingMaria Corina Plaz Torres, Quirino Lai, Fabio Piscaglia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 11, 2012
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosisFranco Trevisani, Antonio Di Micoli, Andrea Zambruni, et al.
Cancers|December 24, 2021
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple ConfoundersLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
The Journal of Surgical Research|April 12, 2005
The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injuryPaolo Caraceni, Marco Domenicali, Gianluigi Vendemiale, et al.
Cancers|March 11, 2023
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular CarcinomaLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
La Radiologia Medica|January 27, 2006
Orthotopic liver transplantation (OLT): Contribution of diagnostic imaging and interventional radiology in preparing the transplantation and managing complications. Part 1: Indications, surgical technique, diagnostic imaging and interventional radiology before transplantation from cadaveric and living donorRita Golfieri, Emanuela Giampalma, Francesca Fusco, et al.
Cardiovascular and Interventional Radiology|April 3, 2020
Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score AnalysisCristina Mosconi, Annagiulia Gramenzi, Maurizio Biselli, et al.
La Radiologia Medica|January 27, 2006
Orthotopic liver transplantation (OLT): Contribution of imaging and interventional radiology in preparing the transplantation and managing complications. Part 2: Post-OLT complications and their treatmentRita Golfieri, Emanuela Giampalma, Francesca Fusco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled studyMaurizio Biselli, Pietro Andreone, Annagiulia Gramenzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2014
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysisAnnagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, et al.
Pageof 21

Showing results (81-90 of 208) with videos related to

Sort By:
Pageof 21
Journal of Clinical Medicine|August 7, 2021
Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life SettingMaria Corina Plaz Torres, Quirino Lai, Fabio Piscaglia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 11, 2012
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosisFranco Trevisani, Antonio Di Micoli, Andrea Zambruni, et al.
Cancers|December 24, 2021
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple ConfoundersLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
The Journal of Surgical Research|April 12, 2005
The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injuryPaolo Caraceni, Marco Domenicali, Gianluigi Vendemiale, et al.
Cancers|March 11, 2023
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular CarcinomaLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
La Radiologia Medica|January 27, 2006
Orthotopic liver transplantation (OLT): Contribution of diagnostic imaging and interventional radiology in preparing the transplantation and managing complications. Part 1: Indications, surgical technique, diagnostic imaging and interventional radiology before transplantation from cadaveric and living donorRita Golfieri, Emanuela Giampalma, Francesca Fusco, et al.
Cardiovascular and Interventional Radiology|April 3, 2020
Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score AnalysisCristina Mosconi, Annagiulia Gramenzi, Maurizio Biselli, et al.
La Radiologia Medica|January 27, 2006
Orthotopic liver transplantation (OLT): Contribution of imaging and interventional radiology in preparing the transplantation and managing complications. Part 2: Post-OLT complications and their treatmentRita Golfieri, Emanuela Giampalma, Francesca Fusco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled studyMaurizio Biselli, Pietro Andreone, Annagiulia Gramenzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2014
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysisAnnagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, et al.
Pageof 21